Texas Instruments
TXN
281.96
+5.81
+2.10%
Texas Instruments
US · TXN
#69 by market cap
Listed 2012
281.96
+5.81
+2.10%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-20 11:00
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 12.02, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.05% YoY
Margins
- Gross margin
- 57.02%
- Operating margin
- 34.72%
- Net margin
- 28.12%
Key ratios & quality
- Enterprise valuei
- 266.67B
- Altman Z-Scorei
- 12.02
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.78B | 14.38B | 14.46B | 18.34B | 20.03B | 17.52B | 15.64B | 17.68B |
| Gross profit | 10.28B | 9.16B | 9.27B | 12.38B | 13.77B | 11.02B | 9.09B | 10.08B |
| Selling & admin expenses | 1.68B | 1.65B | 1.62B | 1.67B | 1.70B | 1.83B | 1.79B | 1.86B |
| Research & development | 1.56B | 1.54B | 1.53B | 1.55B | 1.67B | 1.86B | 1.96B | 2.08B |
| Operating profit | 7.03B | 5.98B | 6.12B | 9.16B | 10.40B | 7.33B | 5.34B | 6.14B |
| Pretax profit | 6.69B | 5.73B | 6.02B | 8.92B | 10.03B | 7.42B | 5.45B | 5.71B |
| Tax | 1.11B | 711.00M | 422.00M | 1.15B | 1.28B | 908.00M | 654.00M | 709.00M |
| Net profit | 5.58B | 5.02B | 5.60B | 7.77B | 8.75B | 6.51B | 4.80B | 5.00B |
| Basic EPS | 6 | 5 | 6 | 8 | 10 | 7 | 5 | 5 |
| Diluted EPS | 5.59 | 5.24 | 5.97 | 8.26 | 9.41 | 7.07 | 5.20 | 5.45 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.07B | 4.45B | 4.74B | 4.42B | 4.83B | 5.46B |
| Gross profit | 2.31B | 2.58B | 2.72B | 2.47B | 2.80B | 3.35B |
| Selling & admin expenses | 472.00M | 485.00M | 457.00M | 446.00M | 464.00M | 490.00M |
| Research & development | 517.00M | 527.00M | 518.00M | 521.00M | 510.00M | 535.00M |
| Operating profit | 1.32B | 1.56B | 1.75B | 1.51B | 1.83B | 2.33B |
| Pretax profit | 1.28B | 1.48B | 1.58B | 1.37B | 1.71B | 2.24B |
| Tax | 97.00M | 183.00M | 220.00M | 209.00M | 169.00M | 258.00M |
| Net profit | 1.18B | 1.30B | 1.36B | 1.16B | 1.55B | 1.98B |
| Basic EPS | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 1.28 | 1.41 | 1.48 | 1.27 | 1.68 | 2.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.10B | 8.76B | 10.24B | 13.69B | 14.02B | 15.12B | 15.03B | 13.75B |
| Cash & ST investments | 4.23B | 5.39B | 6.57B | 9.74B | 9.07B | 8.58B | 7.58B | 4.88B |
| Inventory | 2.22B | 2.00B | 1.96B | 1.91B | 2.76B | 4.00B | 4.53B | 4.80B |
| Total assets | 17.14B | 18.02B | 19.35B | 24.68B | 27.21B | 32.35B | 35.51B | 34.59B |
| Total current liabilities | 2.47B | 2.12B | 2.39B | 2.57B | 2.99B | 3.32B | 3.64B | 3.16B |
| Short-term debt | 749.00M | 500.00M | 550.00M | 500.00M | 500.00M | 599.00M | 750.00M | 500.00M |
| Long-term debt | 4.32B | 5.30B | 6.25B | 7.24B | 8.24B | 10.62B | 12.85B | 13.55B |
| Total liabilities | 8,143,000,000.00 | 9,111,000,000.00 | 10,164,000,000.00 | 11,343,000,000.00 | 12,630,000,000.00 | 15,451,000,000.00 | 18,606,000,000.00 | 18,312,000,000.00 |
| Total equity | 8.99B | 8.91B | 9.19B | 13.33B | 14.58B | 16.90B | 16.90B | 16.27B |
| Retained earnings | 37.91B | 39.90B | 42.05B | 45.92B | 50.35B | 52.28B | 52.26B | 52.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.09B | 14.48B | 13.88B | 13.75B | 13.80B | 15.76B |
| Cash & ST investments | 5.01B | 5.36B | 5.19B | 4.88B | 5.10B | 7.00B |
| Inventory | 4.69B | 4.81B | 4.83B | 4.80B | 4.70B | 4.61B |
| Total assets | 33.76B | 34.93B | 35.00B | 34.59B | 34.39B | 35.88B |
| Total current liabilities | 2.49B | 2.49B | 3.12B | 3.16B | 3.10B | 3.24B |
| Short-term debt | -- | -- | 500.00M | 500.00M | 1.15B | 1.15B |
| Long-term debt | 12.85B | 14.04B | 13.55B | 13.55B | 12.90B | 12.90B |
| Total liabilities | 17,351,000,000.00 | 18,530,000,000.00 | 18,377,000,000.00 | 18,312,000,000.00 | 17,615,000,000.00 | 17,875,000,000.00 |
| Total equity | 16.41B | 16.40B | 16.63B | 16.27B | 16.78B | 18.01B |
| Retained earnings | 52.20B | 52.25B | 52.37B | 52.24B | 52.48B | 53.16B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7.19B | 6.65B | 6.14B | 8.76B | 8.72B | 6.42B | 6.32B | 7.15B |
| Depreciation & amortization | 954.00M | 1.05B | 992.00M | 954.00M | 979.00M | 1.24B | 1.58B | 2.00B |
| Free cash flow | 6.06B | 5.80B | 5.49B | 6.29B | 5.92B | 1.35B | 1.50B | 2.60B |
| Dividends paid | -2.56B | -3.01B | -3.43B | -3.89B | -4.30B | -4.56B | -4.80B | -5.00B |
| Stock buybacks / issuance | -4.73B | -2.42B | -2.08B | -150.00M | -3.37B | -30.00M | -412.00M | -1.08B |
| Ending cash balance | 2.44B | 2.44B | 3.11B | 4.63B | 3.05B | 2.96B | 3.20B | 3.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 849.00M | 1.86B | 2.19B | 2.25B | 1.52B | 2.70B |
| Depreciation & amortization | 444.00M | 481.00M | 517.00M | 557.00M | 562.00M | 568.00M |
| Free cash flow | -274.00M | 555.00M | 993.00M | 1.33B | 844.00M | 2.19B |
| Dividends paid | -1.24B | -1.24B | -1.24B | -1.29B | -1.29B | -1.30B |
| Stock buybacks / issuance | -535.00M | -187.00M | 6.00M | -361.00M | 151.00M | 418.00M |
| Ending cash balance | 2.76B | 3.04B | 3.31B | 3.23B | 3.55B | 3.66B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 57.29 | 56.05 | 61.55 | 68.70 | 62.41 | 41.15 | 28.25 | 29.98 |
| ROA %i | 31.84 | 28.54 | 29.80 | 35.14 | 33.57 | 21.75 | 14.07 | 14.19 |
| ROIC %i | 39.62 | 35.59 | 36.82 | 41.90 | 39.44 | 26.21 | 17.82 | 17.92 |
| 5-year avg ROE %i | 36.52 | 42.42 | 48.94 | 55.73 | 61.13 | 57.90 | 52.41 | 46.10 |
| EBIT margin %i | 43.15 | 41.01 | 42.92 | 49.62 | 51.16 | 44.36 | 38.11 | 35.36 |
| FCF / sales %i | 38.38 | 40.34 | 37.96 | 34.31 | 29.57 | 7.70 | 9.58 | 14.72 |
| Current ratioi | 3.27 | 4.13 | 4.28 | 5.33 | 4.70 | 4.55 | 4.12 | 4.35 |
| Quick ratioi | 2.20 | 3.04 | 3.34 | 4.45 | 3.67 | 3.12 | 2.55 | 2.17 |
| Debt / assetsi | 29.57 | 33.64 | 36.42 | 32.92 | 32.11 | 34.69 | 38.29 | 40.62 |
| LT debt / equityi | 48.02 | 62.45 | 70.72 | 57.18 | 56.49 | 62.88 | 76.00 | 83.25 |
| Interest coveragei | 54.49 | 34.69 | 32.67 | 49.47 | 47.88 | 22.01 | 11.73 | 11.52 |
| Revenue CAGR (3Y) %i | 6.68 | 2.46 | -1.13 | 5.14 | 11.67 | 6.60 | -5.17 | -4.07 |
| Net income CAGR (3Y) %i | 23.17 | 11.75 | 14.97 | 11.66 | 20.37 | 5.18 | -14.83 | -17.01 |
| FCF CAGR (3Y) %i | 16.35 | 12.43 | 5.56 | 1.28 | 0.69 | -37.37 | -38.03 | -23.97 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 29.05 | 29.84 | 29.60 | 29.98 | 32.18 | 34.97 |
| ROA %i | 14.13 | 14.33 | 14.27 | 14.19 | 15.67 | 16.99 |
| ROIC %i | 17.99 | 18.11 | 17.55 | 17.92 | 19.02 | 20.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 37.11 | 37.12 | 36.08 | 35.36 | 36.36 | 38.41 |
| FCF / sales %i | 9.07 | 9.01 | 12.05 | 14.72 | 20.18 | 27.53 |
| Current ratioi | 5.26 | 5.81 | 4.45 | 4.35 | 4.46 | 4.86 |
| Quick ratioi | 3.24 | 3.74 | 2.32 | 2.17 | 2.37 | 3.24 |
| Debt / assetsi | 38.06 | 40.20 | 40.13 | 40.62 | 40.85 | 39.16 |
| LT debt / equityi | 78.31 | 85.61 | 81.47 | 83.25 | 76.89 | 71.66 |
| Interest coveragei | 11.45 | 11.86 | 11.71 | 11.52 | 12.06 | 13.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Analog is the largest reported line at 79.90% of revenue, across 3 reported segments.
- The next-largest line, Embedded Processing, is a distant second at 14.42% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Analog79.90%
Embedded Processing14.42%
Other5.67%
Quote time 2026-10-20 11:00:12 · For reference only, not investment advice and not tailored to your situation.
Texas Instruments discussion 0 comments